Home/Filings/4/0001729149-25-000041
4//SEC Filing

Frazier William 4

Accession 0001729149-25-000041

CIK 0001729149other

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 3:27 PM ET

Size

23.2 KB

Accession

0001729149-25-000041

Insider Transaction Report

Form 4
Period: 2024-01-29
Frazier William
DirectorChief Medical Officer
Transactions
  • Award

    Phantom Share Units

    2025-01-21+2,5502,550 total
    Exp: 2028-01-21Common Shares (2,550 underlying)
  • Exercise/Conversion

    Phantom Share Units

    2025-01-297781,556 total
    Exp: 2027-01-29Common Shares (778 underlying)
  • Tax Payment

    Common Shares

    2025-01-29$8.28/sh693$5,73869,450 total
  • Exercise/Conversion

    Common Shares

    2025-01-29+77870,228 total
  • Disposition to Issuer

    Common Shares

    2025-01-29$8.28/sh778$6,44269,450 total
  • Award

    Restricted Stock Units

    2024-01-29+7,0037,003 total
    Exp: 2027-01-29Common Shares (7,003 underlying)
  • Award

    Phantom Share Units

    2024-01-29+2,3342,334 total
    Exp: 2027-01-29Common Shares (2,334 underlying)
  • Award

    Restricted Stock Units

    2025-01-21+10,20110,201 total
    Exp: 2028-01-21Common Shares (10,201 underlying)
  • Exercise/Conversion

    Common Shares

    2025-01-29+2,33570,143 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-01-292,3354,668 total
    Exp: 2027-01-29Common Shares (2,335 underlying)
Footnotes (10)
  • [F1]Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
  • [F10]Represents an award granted on January 21, 2025 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
  • [F2]Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
  • [F3]Per share value is based on the market closing price of the common shares for January 29, 2025.
  • [F4]Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
  • [F5]This transaction is being reported late due to an administrative error in processing the grant details; the reporting person took immediate steps to rectify the issue upon discovery.
  • [F6]Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date.
  • [F7]Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
  • [F8]Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
  • [F9]Restricted Stock Units (RSUs) granted to reporting person on January 21, 2025, which vest in three equal annual installments beginning on the first anniversary of the grant date.

Issuer

VIEMED HEALTHCARE, INC.

CIK 0001729149

Entity typeother

Related Parties

1
  • filerCIK 0001782067

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 3:27 PM ET
Size
23.2 KB